Applied Genetic Technologies Corporation
AGTC · NASDAQ
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $325 | $0 | $0 |
| % Growth | -100% | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $325 | $0 | $0 |
| % Margin | – | 100% | – | – |
| R&D Expenses | $12,884 | $13,574 | $9,162 | $14,454 |
| G&A Expenses | $4,460 | $4,475 | $4,421 | $3,989 |
| SG&A Expenses | $4,460 | $4,475 | $4,421 | $3,989 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $17,344 | $18,049 | $13,583 | $18,443 |
| Operating Income | -$468 | -$17,723 | -$13,627 | -$19,819 |
| % Margin | – | -5,453.2% | – | – |
| Other Income/Exp. Net | $17,533 | -$2,005 | -$658 | -$669 |
| Pre-Tax Income | $189 | -$18,309 | -$14,241 | -$19,112 |
| Tax Expense | -$16,876 | $663 | $667 | -$675 |
| Net Income | $17,065 | -$18,972 | -$14,908 | -$18,437 |
| % Margin | – | -5,837.5% | – | – |
| EPS | 0.26 | -0.42 | -0.34 | -0.43 |
| % Growth | 161.9% | -23.5% | 20.9% | – |
| EPS Diluted | 0.38 | -0.42 | -0.34 | -0.43 |
| Weighted Avg Shares Out | 45,031 | 45,031 | 43,639 | 42,886 |
| Weighted Avg Shares Out Dil | 45,031 | 45,031 | 43,639 | 42,886 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | -$657 | $663 | $667 | -$675 |
| Depreciation & Amortization | -$16,876 | $382 | $379 | $751 |
| EBITDA | -$17,344 | -$17,341 | -$13,248 | -$18,443 |
| % Margin | – | -5,335.7% | – | – |